首页> 外文期刊>Endocrine journal >Atypical pituitary adenoma with MEN1 somatic mutation associated with abnormalities of DNA mismatch repair genes; MLH1 germline mutation and MSH6 somatic mutation
【24h】

Atypical pituitary adenoma with MEN1 somatic mutation associated with abnormalities of DNA mismatch repair genes; MLH1 germline mutation and MSH6 somatic mutation

机译:具有MEN1体细胞突变的非典型垂体腺瘤,与DNA错配修复基因异常有关; MLH1种系突变和MSH6体细胞突变

获取原文
           

摘要

The mechanism of pituitary tumorigenesis remains largely unknown. Lynch syndrome is an autosomal, dominantly inherited syndrome caused by a defective mismatch repair (MMR) mechanism involved in the development of various tumors at an early age. In this case study, we showed the occurrence of pituitary tumors associated with Lynch syndrome for the first time and performed genetic and immunohistochemical analysis to evaluate the genetic aberrations that might be related to the tumorigenesis and proliferation. A 68-year-old female patient with Lynch syndrome due to mutL homolog 1 (MLH1) gene mutation suffered from hypersecretion of adrenocorticotrophic hormone (ACTH), hypercortisolism and a rapidly progressive pituitary tumor. We performed genetic analysis by whole genome sequencing with genomic DNA of the pituitary tumor and peripheral blood leukocytes, as well as immunohistochemical analysis of MMR proteins. Genetic analysis revealed that the tumor had homozygous gene mutation of MEN1 associated with pituitary tumorigenesis and mutS homolog 6 (MSH6) gene. Furthermore, immunohistochemical analysis showed that MLH1 and MSH6 immunoexpression were negative. We reveal for the first time that MMR abnormality could cause somatic mutation of MEN1 and pituitary tumor occurrence is associated with Lynch syndrome. We suggest that the identified gene mutations, especially those of MSH6 and MLH1 genes, may be involved in the pathogenesis and proliferation of pituitary tumor. The knowledge obtained from our case study is important to elucidate the pathogenesis and proliferation mechanisms of pituitary tumors.
机译:垂体肿瘤发生的机制仍不清楚。林奇综合症是一种常染色体显性遗传综合症,由早期参与各种肿瘤发展的失配修复(MMR)机制引起。在本案例研究中,我们首次显示了与Lynch综合征相关的垂体瘤的发生,并进行了遗传和免疫组织化学分析,以评估可能与肿瘤发生和增殖有关的遗传异常。一名因mutL homolog 1(MLH1)基因突变而患有Lynch综合征的68岁女性患者患有肾上腺皮质营养激素(ACTH)分泌过多,皮质醇过多症和垂体快速进展性肿瘤。我们通过垂体肿瘤和外周血白细胞的基因组DNA的全基因组测序以及MMR蛋白的免疫组织化学分析进行了遗传分析。遗传分析显示,该肿瘤具有与垂体肿瘤发生和mutS homolog 6(MSH6)基因相关的MEN1纯合基因突变。此外,免疫组织化学分析显示MLH1和MSH6免疫表达为阴性。我们首次揭示MMR异常可能引起MEN1的体细胞突变,而垂体瘤的发生与Lynch综合征有关。我们建议,确定的基因突变,尤其是MSH6和MLH1基因的突变,可能与垂体肿瘤的发病和增殖有关。从我们的案例研究中获得的知识对于阐明垂体肿瘤的发病机理和增殖机制非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号